A detailed history of Cresset Asset Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 6,754 shares of CRL stock, worth $1.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,754
Previous 5,943 13.65%
Holding current value
$1.34 Million
Previous $1.23 Million 8.39%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $152,435 - $198,930
811 Added 13.65%
6,754 $1.33 Million
Q2 2024

Aug 14, 2024

SELL
$206.39 - $268.73 $21,670 - $28,216
-105 Reduced 1.74%
5,943 $1.23 Million
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $5,291 - $7,109
-26 Reduced 0.43%
6,048 $1.64 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $144,119 - $209,223
-876 Reduced 12.6%
6,074 $1.44 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $497,377 - $556,646
2,558 Added 58.24%
6,950 $1.36 Million
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $806,854 - $923,418
4,392 New
4,392 $923,000
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $170,169 - $241,165
-666 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$351.38 - $448.68 $351 - $448
1 Added 0.15%
666 $250,000
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $46,207 - $56,829
124 Added 22.92%
665 $274,000
Q2 2021

Aug 10, 2021

BUY
$294.17 - $371.65 $159,145 - $201,062
541 New
541 $200,000
Q2 2019

Aug 12, 2019

SELL
$123.4 - $148.55 $39,981 - $48,130
-324 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $16,456 - $23,036
157 Added 94.01%
324 $47,000
Q4 2018

May 21, 2019

BUY
$105.09 - $137.23 $17,550 - $22,917
167 New
167 $19,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.